Analyst Ratings for Reata Pharmaceuticals (RETA) [Buys]
RETA Rating Summary
RETA Price Target Summary
- Highest: $173.00 (Baird)
- Lowest: $115.00 (Leerink Partners)
- Average: $161.88
* Over Last 12-Mos
Overall Rating:
NEUTRAL
Rating Trend:
Avg. $ Target:
$161.88 (-6.1%)
* Over Last 12-Mos
Rating Score: 4.3 / 10
Percentile Rank: 43%
Avg. $ Target:
$161.88 (-6.1%)
* Over Last 12-Mos
Rating Score: 4.3 / 10
Percentile Rank: 43%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 6/12/2023 | Leerink Partners | Joseph P. Schwartz | Upgrade | Outperform (Market Perform) |
115.00 (80.00) |
93.80 (172.36) |
83.75% | Details |
| 10/19/2022 | Guggenheim » Updated 3/1/2023 |
Yatin Suneja | New Coverage | Buy (N/A) |
130.00 (75.00) |
36.50 (172.36) |
372.22% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
